BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 15660234)

  • 1. Effects of Nasal Calcitonin vs. Oral Gabapentin on Pain and Symptoms of Lumbar Spinal Stenosis: A Clinical Trial Study.
    Haddadi K; Asadian L; Isazade A
    Clin Med Insights Arthritis Musculoskelet Disord; 2016; 9():133-8. PubMed ID: 27398032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral calcitonin.
    Hamdy RC; Daley DN
    Int J Womens Health; 2012; 4():471-9. PubMed ID: 23071417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal salcatonin (salmon calcitonin). A review of its pharmacological properties and role in the management of postmenopausal osteoporosis.
    Plosker GL; McTavish D
    Drugs Aging; 1996 May; 8(5):378-400. PubMed ID: 8935399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcitonin therapy in osteoporosis.
    Muñoz-Torres M; Alonso G; Raya MP
    Treat Endocrinol; 2004; 3(2):117-32. PubMed ID: 15743107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of cyclic and continuous calcitonin regimens in the treatment of postmenopausal osteoporosis.
    Tekeoğlu I; Adak B; Budancamanak M; Demirel A; Ediz L
    Rheumatol Int; 2005 Dec; 26(2):157-61. PubMed ID: 15660234
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intermittent administration of 200 IU intranasal salmon calcitonin and low doses of 1alpha(OH) vitamin D3 on bone mineral density of the lumbar spine and hip region and biochemical bone markers in women with postmenopausal osteoporosis: a pilot study.
    Kaskani E; Lyritis GP; Kosmidis C; Galanos A; Andypas G; Chorianopoulos K; Giagiosis A; Iliadou K; Karagianis A; Katsimichas K; Koskinas A; Matsouka K
    Clin Rheumatol; 2005 Jun; 24(3):232-8. PubMed ID: 15647969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of osteoporosis in patients with rheumatoid arthritis receiving glucocorticoids: a comparison of alendronate and intranasal salmon calcitonin.
    Tascioglu F; Colak O; Armagan O; Alatas O; Oner C
    Rheumatol Int; 2005 Nov; 26(1):21-9. PubMed ID: 15688191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the Oral Calcitonin in Postmenopausal Osteoporosis (ORACAL) trial.
    Binkley N; Bolognese M; Sidorowicz-Bialynicka A; Vally T; Trout R; Miller C; Buben CE; Gilligan JP; Krause DS;
    J Bone Miner Res; 2012 Aug; 27(8):1821-9. PubMed ID: 22437792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of different treatment modalities for postmenopausal patients with osteopenia: hormone replacement therapy, calcitonin and clodronate.
    Tiraş MB; Noyan V; Yildiz A; Biberoğlu K
    Climacteric; 2000 Jun; 3(2):92-101. PubMed ID: 11910657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal salmon calcitonin in postmenopausal osteoporosis: effect of different therapeutic regimens on vertebral and peripheral bone density.
    Perrone G; Galoppi P; Valente M; Capri O; D'Ubaldo C; Anelli G; Zichella L
    Gynecol Obstet Invest; 1992; 33(3):168-71. PubMed ID: 1612530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of osteoporosis in postmenopausal women: focus on safety.
    Reid IR
    Expert Opin Drug Saf; 2002 May; 1(1):93-107. PubMed ID: 12904164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in osteoporosis therapy. 2003 update of practical guidelines.
    Khan A
    Can Fam Physician; 2003 Apr; 49():441-7. PubMed ID: 12729240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing therapies for postmenopausal osteoporosis prevention and treatment.
    Eichner SF; Lloyd KB; Timpe EM
    Ann Pharmacother; 2003 May; 37(5):711-24. PubMed ID: 12708951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoporosis in elderly: prevention and treatment.
    Srivastava M; Deal C
    Clin Geriatr Med; 2002 Aug; 18(3):529-55. PubMed ID: 12424871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The analgesic role of calcitonin following osteoporotic fracture.
    Silverman SL; Azria M
    Osteoporos Int; 2002 Nov; 13(11):858-67. PubMed ID: 12415432
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.